The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 120.00
Bid: 118.00
Ask: 122.00
Change: 7.50 (6.67%)
Spread: 4.00 (3.39%)
Open: 117.50
High: 120.50
Low: 117.50
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Oct 2011 15:00

7 October 2011

ECO ANIMAL HEALTH GROUP PLC

("the Company")

Reorganisation of employee and director share option scheme and subsequent Directors' Dealing

The Company announces that certain directors have been requested by the board to exercise some of their unapproved share options and they have agreed to commit to the terms, rules and risks of a joint share ownership plan (JSOP), which will also largely replace the directors' remaining, unvested, unapproved share options. The JSOP awards will result in an immediate personal tax charge for each director based on the market value of their part interest in the shares issued, but will more closely align their interests with those of other shareholders, since the directors will only benefit from future gains in the share price above a 5.9% per annum minimum rise. The tax charge and the minimum growth rate represent risks to the participants which were not present in the previously existing unapproved option awards. Furthermore, the new jointly owned shares which replace the exercised options have an additional three year vesting period, while the vested unapproved options might have been exercised at any time. The Company anticipates offering the opportunity to participate in the JSOP to certain senior management in the near future. The total of newly issued jointly owned shares and remaining exercisable options will not be more than the number of options which previously existed and will remain capped at 10% of the number of ordinary shares in issue. A summary of the transactions by directors and resultant holdings is shown below

Name of director No. of options exercised and shares sold Exercise price paid Sale price per share
Marc Loomes 556,110 £1.085 £1.94
Marc Loomes 100,000 £0.85 £1.94

Brett Clemo

32,360

£1.085

£1.94

Brett Clemo 50,000 £0.85 £1.94
Julia Trouse 178,460 £1.085 £1.94
Julia Trouse 50,000 £0.85 £1.94
Kevin Stockdale 22,360 £1.085 £1.94
Kevin Stockdale 50,000 £0.85 £1.94

Name of director Interests in jointly owned shares under the JSOP Subscription price paid by the Employee Benefit Trust Revised holding of interests in jointly owned shares and options
Marc Loomes 906,110 £1.94 933,750
Brett Clemo 282,360 £1.94 310,000
Julia Trouse 393,460 £1.94 421,100
Kevin Stockdale 237,360 £1.94 265,000

Disclosure and Transparency Rules

In accordance with the FSA's Disclosure and Transparency Rules, the Company's issued share capital following the admission of the new 1,819,290 Ordinary Shares will comprise 54,246,451 ordinary shares of 5p with voting rights. These shares are expected to be admitted to trading on 12 October 2011. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Enquiries:

ECO Animal Health Group plc Kevin Stockdale, Finance Director

Peter Lawrence , Chairman

tel: 0208 336 6186

tel: 0208 336 6190

Cenkos Securites plc (Nominated advisor) Elizabeth Bowman tel: 0207 397 8928

Copyright Business Wire 2011

Date   Source Headline
8th May 20247:00 amRNSRisk Profile Demonstrated for ECOVAXXIN MS
25th Apr 20247:00 amRNSTrading Update on year ended 31 March 2024
8th Apr 20247:00 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSDisposal of non-core product line
22nd Mar 20247:00 amRNSShare Awards to Executive Directors
21st Mar 20249:13 amRNSReplacement: Trading Update
21st Mar 20247:00 amRNSTrading Update
19th Mar 20249:40 amRNSGeneral Meeting Result
27th Feb 20247:00 amRNSPublication of Notice of General Meeting
6th Feb 20247:00 amRNSTrademark Approval for ECOVAXXIN® family in the EU
8th Jan 20247:00 amRNSDisposal of Freehold Properties
5th Jan 20245:05 pmRNSHolding(s) in Company
5th Jan 20245:00 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSDeferred Option Awards to Executive Directors
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 202310:00 amRNSInvestor Presentation
27th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
14th Nov 20233:00 pmRNSHolding(s) in Company
9th Nov 20237:00 amRNSCapital Markets Day Events
24th Oct 20237:00 amRNSNew USA and Canada label claim for Aivlosin®
28th Sep 20237:00 amRNSESG Rating
7th Sep 20232:57 pmRNSResult of AGM
10th Aug 20237:00 amRNSNotice of AGM
21st Jul 20234:25 pmRNSPosting of the Annual Report and Accounts
10th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
5th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jun 20237:00 amRNSIssue of Equity and Total Voting Rights
18th May 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSTrading Update
8th Mar 20237:00 amRNSAnimal Health Innovation Summit
27th Feb 202310:37 amRNSDirector/PDMR Shareholding
24th Feb 20233:19 pmRNSChange of Registered Address
17th Feb 20231:41 pmRNSHolding(s) in Company
13th Feb 20231:55 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Jan 202312:14 pmRNSHolding(s) in Company
13th Dec 20223:50 pmRNSDeferred Share Option Awards
30th Nov 20223:01 pmRNSDirector/PDMR Shareholding
25th Nov 20221:37 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSResults for the six months ended 30 September 2022
22nd Nov 20227:00 amRNSInvestor Presentation covering Interim Results
14th Nov 20227:00 amRNSChange of Auditor
31st Oct 20227:00 amRNSBlock listing Interim Review
24th Oct 20221:30 pmRNSHolding(s) in Company
24th Oct 20221:28 pmRNSHolding(s) in Company
26th Sep 20224:01 pmRNSResult of AGM
5th Sep 20221:00 pmRNSInvestor Presentation covering Full Year Results
2nd Sep 20227:00 amRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.